The people behind the platform
Building scalable, AI-enabled tools to advance diagnostic equity, from Austin, TX to labs worldwide.
The biggest disruptor in clinical pathology is democratization through advanced automation: accelerating every pathologist, at every lab, for every patient, with AI bringing precision and quality diagnosis at the speed and scale healthcare has always needed.
Rishik Kolpekwar is the founder and inventor behind MedMorphIQ, whose patent (US 18,368,348) has been published by the USPTO. A computer scientist and biomedical researcher at The University of Texas at Austin, he builds advanced technology to solve real-world challenges in cancer diagnostics, driven by a commitment to diagnostic equity through scalable, AI-enabled tools.
MedMorphIQ took 1st Place at the Texas Engineering World Health Innovation Competition (2026), was accepted into UT Austin’s selective SEAL accelerator, and has been endorsed by the National Science Foundation’s I-Corps program. Today it runs on real patient workloads across partner institutions in the US and India.
His research background spans the TAME-Pain project, an international collaboration between UT Austin, Nottingham, and Southampton where he ran experimental pain-induction studies and built Python tools to surface signal trends across pain phenotypes (published on MIT’s PhysioNet platform), and work at Wayne State University’s School of Medicine researching AI applications in digital pathology, which deepened his focus on integrating smart systems into real clinical workflows.